Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
News Medical on MSN
Pioneering technology enables scalable production of human kidney organoids
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...
DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. This ...
CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes achieve insulin independence within the year, a small phase I/II study ...
News-Medical.Net on MSN
Breakthrough could offer a new therapeutic option for stopping diabetes-induced complications
Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...
Approximately 9.5 million people globally live with Type 1 diabetes, a chronic autoimmune disease where T cells from the body’s immune system destroy insulin-producing cells in the pancreas, which are ...
Medindia on MSN
Gene-Edited Cells Restore Insulin in Diabetes Patient
People with Type 1 diabetes lose insulin-producing beta cells due to an autoimmune reaction, forcing lifelong dependence on ...
WESTLAKE VILLAGE, Calif. - The U.S. Food and Drug Administration has accepted MannKind Corporation’s (NASDAQ:MNKD) supplemental biologics license application for Afrezza Inhalation Powder for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback